World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

IMPACT OF VITILIGO ON QUALITY OF LIFE: A MULTI-CENTERED, CROSS-SECTIONAL, OBSERVATIONAL STUDY

Dr. Mustakim M. Mansuri*, Yesha M. Trivedi, Abhi Antala, Khushi R. Patel

ABSTRACT

Vitiligo, a chronic skin condition characterized by depigmented patches, which affects patients' quality of life (QoL). The present study was conducted to assess the QoL of vitiligo patients was conducted in a total of 131 patients, with a nearly equal gender distribution (54.20% male, 45.80% female), predominantly from Gujarat (74.81%). The study used a "Vitiligo Life Check" questionnaire to evaluate the social and mental impact of vitiligo, comparing patients' initial and present QoL. The results revealed that 61.8 percentage of patients initially experienced a moderate impact on QoL, and which was reduced to 25.95% with treatment, indicating some improvement over time. However, female patients reported significantly worse scores in mental and social domains compared to male patients, suggesting gender differences in coping with the condition. Additionally, 22.9% of patients reported depression, underscoring the psychological burden of vitiligo. The study concludes that while some patients have experienced improvements in their QoL, vitiligo continues to have a significant psychosocial impact, especially among women. Addressing both the physical and emotional aspects of vitiligo is crucial for improving patient well-being. Effective treatment should include not only dermatological interventions but also psychological support to reduce the stigma and enhance coping mechanisms. This study highlights the importance of ongoing QoL assessments in vitiligo patients and advocates for integrated care involving both dermatologists and mental health professionals to improve the overall well-being of individuals affected by the condition.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR